All Stories

  1. Potential resource and cost saving analysis of subcutaneous versus intravenous administration for rituximab in non-Hodgkin’s lymphoma and for trastuzumab in breast cancer in 17 Italian hospitals based on a systematic survey [Corrigendum]

    Article • ClinicoEconomics and Outcomes Research, January 2017, Dove Medical Press

    Monica Canciani, Stefan Walzer

  2. Administrative risk quantification of subcutaneous and intravenous therapies in Italian centers utilizing the Failure Mode and Effects Analysis approach

    Article • ClinicoEconomics and Outcomes Research, August 2016, Dove Medical Press

    Monica Canciani, Stefan Walzer

  3. Potential resource and cost saving analysis of subcutaneous versus intravenous administration for rituximab in non-Hodgkin's lymphoma and for trastuzumab in breast cancer in 17 Italian hospitals based on a systematic survey

    Article • ClinicoEconomics and Outcomes Research, May 2016, Dove Medical Press

    Monica Canciani, Stefan Walzer